The EXPANDER-1 trial: introduction of the novel Urocross Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
Woo HH, Huang CP, Huang WJ, Chang YH, Lien CS, Chkhotua A, Elterman DS.
Prostate Cancer Prostatic Dis. 2022 Sep;25(3):576-582. doi: 10.1038/s41391-022-00548-z. Epub 2022 May 31.
PMID:35641601
Covered metallic stents in the management of malignant and benign pancreatobiliary strictures.
Isayama H, Nakai Y, Togawa O, Kogure H, Ito Y, Sasaki T, Sasahira N, Hirano K, Tsujino T, Tada M, Kawabe T, Omata M.